Evidence map›Paper›PMID 32957704›Full record

ArticleVaccines2020

Control of Cytoskeletal Dynamics by β-Arrestin1/Myosin Vb Signaling Regulates Endosomal Sorting and Scavenging Activity of the Atypical Chemokine Receptor ACKR2.

Alessandro Vacchini, Cinzia Cancellieri, Samantha Milanesi, Sabrina Badanai, Benedetta Savino, Francesco Bifari, Massimo Locati, Raffaella Bonecchi, Elena Monica Borroni

Abstract read
In one paragraph

Article in Vaccines, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Atypical chemokine receptors in the immune system.Nature reviews. Immunology · 2024
    Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Alessandro VacchiniHumanitas Clinical and Research Center-IRCCS, 20089 Rozzano (Mi), Italy.
Cinzia CancellieriHumanitas Clinical and Research Center-IRCCS, 20089 Rozzano (Mi), Italy.
Samantha MilanesiHumanitas Clinical and Research Center-IRCCS, 20089 Rozzano (Mi), Italy.ORCID 0000-0001-8055-1686
Sabrina BadanaiHumanitas Clinical and Research Center-IRCCS, 20089 Rozzano (Mi), Italy.
Benedetta SavinoHumanitas Clinical and Research Center-IRCCS, 20089 Rozzano (Mi), Italy.ORCID 0000-0002-2996-9515
Francesco BifariDepartment of Medical Biotechnologies and Translational Medicine, University of Milan, 20090 Milan, Italy.ORCID 0000-0003-2028-3012
Massimo LocatiHumanitas Clinical and Research Center-IRCCS, 20089 Rozzano (Mi), Italy.
Raffaella BonecchiHumanitas Clinical and Research Center-IRCCS, 20089 Rozzano (Mi), Italy.
Elena Monica BorroniHumanitas Clinical and Research Center-IRCCS, 20089 Rozzano (Mi), Italy.ORCID 0000-0003-1157-8249

Funding

European Community's Seventh Framework Program FP7-2007-2013 under grant agreement HEALTH-F4-2011-281608 (TIMER)Ministero dell'Istruzione dell'Università e della Ricerca FIRB project RBFR08CW8GMinistero dell'Istruzione dell'Università e della Ricerca PRIN project 2009JP9WTS_002
6 · The paper itself

Abstract

The atypical chemokine receptor ACKR2, formerly named D6, is a scavenger chemokine receptor with a non-redundant role in the control of inflammation and immunity. The scavenging activity of ACKR2 depends on its trafficking properties, which require actin cytoskeleton rearrangements downstream of a β-arrestin1-Rac1-PAK1-LIMK1-cofilin-dependent signaling pathway. We here demonstrate that in basal conditions, ACKR2 trafficking properties require intact actin and microtubules networks. The dynamic turnover of actin filaments is required to sustain ACKR2 constitutive endocytosis, while both actin and microtubule networks are involved in processes regulating ACKR2 constitutive sorting to rapid, Rab4-dependent and slow, Rab11-dependent recycling pathways, respectively. After chemokine engagement, ACKR2 requires myosin Vb activity to promote its trafficking from Rab11-positive recycling endosomes to the plasma membrane, which sustains its scavenging activity. Other than cofilin phosphorylation, induction of the β-arrestin1-dependent signaling pathway by ACKR2 agonists also leads to the rearrangement of microtubules, which is required to support the myosin Vb-dependent ACKR2 upregulation and its scavenging properties. Disruption of the actin-based cytoskeleton by the apoptosis-inducing agent staurosporine results in impaired ACKR2 internalization and chemokine degradation that is consistent with the emerging scavenging-independent activity of the receptor in apoptotic neutrophils instrumental for promoting efficient efferocytosis during the resolution of inflammation. In conclusion, we provide evidence that ACKR2 activates a β-arrestin1-dependent signaling pathway, triggering both the actin and the microtubule cytoskeletal networks, which control its trafficking and scavenger properties.

Indexed as

ACKR2chemokinecytoskeletonmyosin Vbβ-arrestin1

Identifiers

PMID32957704
PMCPMC7565953

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.